References
- Simon GA, Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations-an overview. Skin Pharmacol Appl Skin Physiol. 2000; 13(5): 229-234. https://doi.org/10.1159/000029928
- Elias PM, Feingold KR, Fluhr JW. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill. 2003.
- Rogers J, Harding C, Mayo A, Banks J, Rawlings A. Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res. 1996; 288: 765-770. https://doi.org/10.1007/BF02505294
- Fisher GJ, Kang S, Varani J. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002; 138: 1462-1470.
- Moser K, Kriwet K, Naik A, Kalia YN, Guy RH. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm. 2001; 52: 103-112. https://doi.org/10.1016/S0939-6411(01)00166-7
- Ackermann K, Borgia SL, Korting HC, Mewes KR, Schafer-Korting M. The Phenion full-thickness skin model for percutaneous absorption testing. Skin Pharmacol Physiol. 2010; 23: 105-12. https://doi.org/10.1159/000265681
- Brain KR, Walters KA, Green DM. Percutaneous penetration of diethanolamine through human skin in vitro: application from cosmetic vehicles. Food Chem Toxicol. 2005; 43: 681-690. https://doi.org/10.1016/j.fct.2004.12.021
- Mickelsen RL, Hall RC, Chern RT, Myers JR. Evaluation of a simple weight-loss method for determining the permeation of organic liquids through rubber films. Am Ind Hyg Assoc J. 2005; 52: 445-447.
- Riviere JE, Brooks JD. Predicting skin permeability from complex chemical mixtures. Toxicol Appl Pharmacol. 2005; 208: 99-110. https://doi.org/10.1016/j.taap.2005.02.016
- Scientific Committee on Cosmetic Products and Non-Food Products (SCCNFP). Opinion concerning "Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients." SCCNFP/0750/03. 2003.
- Reichling J, Landvatter U, Wagner H, Kostka KH, Schaefer UF. In vitro studies on release and human skin permeation of Australian tea tree oil (TTO) from topical formulations. Eur J Pharm Biopharm. 2006; 64: 222-228. https://doi.org/10.1016/j.ejpb.2006.05.006
- Pappinen S, Tikkinen S, Pasonen-Seppanen S, Murtomaki L, Suhonen M, Urtti A. Rat epidermal keratinocyte organotypic culture (ROC) compared to human cadaver skin: The effect of skin permeation enhancers. Eur J Pharm Sci. 2007; 30: 240-250. https://doi.org/10.1016/j.ejps.2006.11.013
- Rohr UD, Laurent H, Gunther C, Riedl J, Esperling P, Tauber U. Prodrug of gestodene for matrixtype transdermal drug delivery system. Pharm Res. 1998; 15: 1419-1424. https://doi.org/10.1023/A:1011957822961
- OECD. OECD guideline for the testing of chemicals, 2004; NO. 428: Skin absorption: in vitro method.
- Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED, Hamilton MG. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig. Hum Exp Toxicol. 2005; 24: 347-352. https://doi.org/10.1191/0960327105ht537oa
- Nielsen JB, Plasencia I, Sorensen JA, Bagatolli LA. Storage conditions of skin affect tissue structure and subsequent in vitro percutaneous penetration. Skin Pharmacol Physiol. 2011; 24: 93-102. https://doi.org/10.1159/000322304
- Potard G, Laugel C, Baillet A, Schaefer H, Marty JP. Quantitative HPLC analysis of sunscreens and caffeine during in vitro percutaneous penetration studies. Int J Pharm. 1999; 189: 249-260. https://doi.org/10.1016/S0378-5173(99)00258-6
- van de Sandt JJ, van Burgsteden JA, Cage S, Carmichael PL, Dick I, Kenyon S, Korinth G, Larese F, Limasset JC, Maas WJ, Montomoli L, Nielsen JB, Payan JP, Robinson E, Sartorelli P, Schaller KH, Wilkinson SC, Williams FM. In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul Toxicol Pharmacol. 2004; 39(3): 271-281. https://doi.org/10.1016/j.yrtph.2004.02.004
- Guth K, Schafer-Korting M, Fabian E, Landsiedel R, van Ravenzwaay B. Suitability of skin integrity tests for dermal absorption studies in vitro. Toxicol In Vitro 2015; 29(1): 113-123. https://doi.org/10.1016/j.tiv.2014.09.007
- Franz TJ. On the relevance of in vitro data. J Invest Dermatol. 1975; 93: 633-640.
- Levintova Y, Plakogiannis FM, Bellantone RA. An improved in vitro method for measuring skin permeability that controls excess hydration of skin using modified Franz diffusion cells. Int J Pharm. 2011; 419: 96-106. https://doi.org/10.1016/j.ijpharm.2011.07.025
- Barber ED, Hill T, Schum DB. The percutaneous absorption of hydroquinone (HQ) through rat and human skin in vitro. Toxicol Lett. 1995; 80: 167-172. https://doi.org/10.1016/0378-4274(95)03393-Y
- Yamashita F, Yoshioka T, Koyama Y, Okamoto H, Sezaki H, Hashida M. Analysis of skin penetration enhancement based on a two-layer skin diffusion model with polar and nonpolar routes in the stratum corneum: dose-dependent effect of 1-geranylazacycloheptan-2-one on drugs with different lipophilicities. Biol Pharm Bull. 1993; 16(7): 690-697. https://doi.org/10.1248/bpb.16.690
- Wilkinson SC, Maas WJ, Nielsen JB, Greaves LC, van de Sandt JJ, Williams FM. Interactions of skin thickness and physicochemical properties of test compounds in percutaneous penetration studies. Int Arch Occup Environ Health 2006; 79: 405-413. https://doi.org/10.1007/s00420-005-0056-5